Power Law company profile

Principia BioPharma

Biotech & Life Sciences · San Francisco, United States · Founded 2008 · IPO 2018 Unicorn

Biopharmaceutical company focused on oncology and autoimmune disease

Valuation

$3.68B

Market cap · 2026

Revenue

$75M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

7 investors on Principia BioPharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

New Leaf Venture Partners

Series B+ 6 investors entered at this stage

Sofinnova Investments

Cormorant Asset Management

Mission Bay Capital

Morgenthaler Ventures

OrbiMed

SR One

Principia BioPharma mafia

Startups founded by Principia BioPharma alumni

Former Principia BioPharma employees who went on to start their own companies. Sorted by Dealroom signal score.

Corvus PharmaceuticalsEst. 2014

Richard Miller, MDUnited States

Signal score84

Silverback TherapeuticsEst. 2016

Peter ThompsonUnited States

Signal score79

Kezar Life SciencesEst. 2015

JTJack TauntonUnited States

Signal score61

PotboticsEst. 2013

David GoldsteinUnited States

Signal score54

Book a demo to explore the full alumni network →

Global footprint

Where Principia BioPharma has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

120 monthly visits
across markets

🇺🇸 United States83.3%

Top 1 markets shown

Patent intelligence

$95M patent portfolio · 70 active families

Estimated portfolio value

$95M

2.6% of market cap · 8.2× smaller than top peer BioNTech ($780M)

70 active patent families

Where Principia BioPharma innovates PiperidinePhenyl groupPyrazoleMolecular biologyCarbonyl group

Where Principia BioPharma concentrates vs peers

Each axis is a top-10 topic across Principia BioPharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Principia BioPharma

An AI-synthesized read of the highest-engagement posts about Principia BioPharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Principia BioPharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles